Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$5,108,606
+$115,186 QoQ
Shares Held
20,115
-1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
#1,598
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Acropolis Investment Management, LLC holds $13,272,644 across 8 Drug Manufacturers - General names. JNJ ranks #1 (38.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
20,115 | $5,108,606 | |
| 2 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 3 | ABBV |
AbbVie Inc.
|
7,039 | $1,771,293 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,768 | $1,769,188 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
17,771 | $1,023,965 | |
| 6 | AMGN |
Amgen Inc
|
1,487 | $538,472 | |
| 7 | PFE |
Pfizer Inc
|
18,379 | $442,566 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,606 | $202,902 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,108,606 | 20,115 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,993,420 | 20,428 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $4,298,972 | 20,773 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $4,049,201 | 21,838 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $3,146,344 | 20,598 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $3,410,002 | 20,562 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $2,996,092 | 20,717 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $3,574,233 | 22,055 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,167,433 | 21,671 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $3,392,700 | 21,447 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $3,367,088 | 21,482 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $3,382,422 | 21,717 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $3,593,935 | 21,713 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $3,610,570 | 23,294 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $4,081,498 | 23,105 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $3,445,752 | 21,093 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $3,768,892 | 21,232 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $3,817,002 | 21,537 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $3,474,944 | 20,313 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $3,286,848 | 20,352 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $3,424,285 | 20,786 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $3,482,576 | 21,190 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $3,209,292 | 20,392 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $2,975,515 | 19,986 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $2,762,676 | 19,645 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $2,608,175 | 19,890 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||